ATE365544T1 - Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon - Google Patents
Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davonInfo
- Publication number
- ATE365544T1 ATE365544T1 AT02722540T AT02722540T ATE365544T1 AT E365544 T1 ATE365544 T1 AT E365544T1 AT 02722540 T AT02722540 T AT 02722540T AT 02722540 T AT02722540 T AT 02722540T AT E365544 T1 ATE365544 T1 AT E365544T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- deconstanting
- anthistaminic
- production
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2002/001068 WO2003084510A1 (en) | 2002-04-04 | 2002-04-04 | Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE365544T1 true ATE365544T1 (de) | 2007-07-15 |
Family
ID=28686908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02722540T ATE365544T1 (de) | 2002-04-04 | 2002-04-04 | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon |
Country Status (7)
Country | Link |
---|---|
US (1) | US8263124B2 (de) |
EP (1) | EP1490034B1 (de) |
AT (1) | ATE365544T1 (de) |
AU (1) | AU2002253425B2 (de) |
CA (1) | CA2481377A1 (de) |
DE (1) | DE60220953T2 (de) |
WO (1) | WO2003084510A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL366576A1 (en) * | 2001-04-09 | 2005-02-07 | Teva Pharmaceutical Industries Ltd. | Polymorphs of fexofenadine hydrochloride |
ES2239554T1 (es) | 2002-06-10 | 2005-10-01 | Teva Pharmaceutical Industries Ltd. | Forma xvi polimorfica de hidrocloruro de fexofenadina. |
EP1675550A4 (de) * | 2003-09-24 | 2007-10-10 | Combinatorx Inc | Therapeutische schemata zur verabreichung arzneimittelkombinationen |
US20080085311A1 (en) * | 2006-10-05 | 2008-04-10 | Tripathi Sanjay S | Antihistamine-decongestant combinations |
WO2008114280A1 (en) * | 2007-03-21 | 2008-09-25 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
US4996061A (en) * | 1987-10-07 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol-decongestant combination |
KR100514264B1 (ko) | 1997-08-26 | 2005-09-15 | 아벤티스 파마슈티칼스 인크. | 피페리디노알칸올-충혈완화제 조합용 제약 조성물 |
PT1035834E (pt) * | 1997-12-05 | 2002-09-30 | Alza Corp | Forma de dosagem osmotica que compreende primeiro e segundo revestimentos |
US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
JP2003532671A (ja) | 2000-05-05 | 2003-11-05 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | シュウドエフェドリン塩酸塩およびフェキソフェナジン塩酸塩の包装の規格化 |
US6613906B1 (en) | 2000-06-06 | 2003-09-02 | Geneva Pharmaceuticals, Inc. | Crystal modification |
PL366576A1 (en) | 2001-04-09 | 2005-02-07 | Teva Pharmaceutical Industries Ltd. | Polymorphs of fexofenadine hydrochloride |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
CA2560882A1 (en) * | 2004-04-26 | 2005-11-03 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
-
2002
- 2002-04-04 DE DE60220953T patent/DE60220953T2/de not_active Expired - Fee Related
- 2002-04-04 AT AT02722540T patent/ATE365544T1/de not_active IP Right Cessation
- 2002-04-04 EP EP02722540A patent/EP1490034B1/de not_active Expired - Lifetime
- 2002-04-04 AU AU2002253425A patent/AU2002253425B2/en not_active Ceased
- 2002-04-04 CA CA002481377A patent/CA2481377A1/en not_active Abandoned
- 2002-04-04 US US10/510,064 patent/US8263124B2/en not_active Expired - Fee Related
- 2002-04-04 WO PCT/IB2002/001068 patent/WO2003084510A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2003084510A1 (en) | 2003-10-16 |
EP1490034B1 (de) | 2007-06-27 |
EP1490034A1 (de) | 2004-12-29 |
AU2002253425B2 (en) | 2008-09-25 |
DE60220953T2 (de) | 2008-02-28 |
DE60220953D1 (de) | 2007-08-09 |
US20060182800A1 (en) | 2006-08-17 |
AU2002253425A1 (en) | 2003-10-20 |
CA2481377A1 (en) | 2003-10-16 |
US8263124B2 (en) | 2012-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE397933T1 (de) | Kristallinform gamma-d von ivabradine- hydrochlorid, verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung | |
ATE397605T1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
HK1084590A1 (en) | Pharmaceutical composition for transdermal or transmucosal administration | |
ATE519486T1 (de) | Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer | |
ATE397449T1 (de) | Kristallinform beta-d von ivabradine-hydrochlorid,verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung | |
HUP0303876A3 (en) | Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv | |
IL175444A (en) | History of hydroxy peipridine, a method of synthesis of history, an in vitro method of inhibition, an improvement in activity and stabilization of glucocerebrosidase, a pharmaceutical preparation, an in vitro method of beta-glucosidase inhibition, and a history of drug preparation | |
ATE454138T1 (de) | Tablette mit modifizierter freisetzung von bupropion hydrochlorid | |
MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
AU2003235381A1 (en) | Method for preparing polymer micelle pharmaceutical preparation containing drug for injection | |
ATE396974T1 (de) | Krystallinform gamma von ivabradine-hydrochlorid, verfahren zu dessen herstellung und diesen enthaltende pharamazeutische zusammensetzung | |
NO20053119D0 (no) | Farmasoytiske sarmmensetninger med fentanyl for intranasal administrasjon. | |
DE602005011326D1 (de) | Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid | |
BRPI0413393A (pt) | fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina | |
DE60317803D1 (de) | Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung | |
HUP0200438A3 (en) | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
TW200606164A (en) | New compounds | |
MY145581A (en) | Combination of ferroquine and an artemisinin derivative for the treatment of malaria | |
ATE374172T1 (de) | Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
BRPI0509524A (pt) | formas cristalinas de n-desmetilclozapina | |
EA200401515A1 (ru) | Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а | |
ATE358477T1 (de) | Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat | |
DE602004024417D1 (de) | Neues verfahren zur herstellung von pleuromutilinderivaten | |
ATE503749T1 (de) | Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
IL164903A0 (en) | Processes for preparation of polymorphic form II of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |